Financial News
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm
Los Angeles - (NewMediaWire) - November 17, 2021 - The Schall Law Firm, a national shareholder rights litigation firm,
announces that it is investigating claims on behalf of investors of CareDx,
Inc (“CareDx” or “the Company”) (NASDAQ: CDNA) for
violations of the securities laws.
The investigation focuses on whether the Company
issued false and/or misleading statements and/or failed to disclose information
pertinent to investors. CareDx released its Q3 2021 results on October 28,
2021. The Company disclosed that the DOJ had opened an investigation of its
kidney testing and phlebotomy services. The Company also disclosed that the SEC
is investigating it on similar matters as well as accounting and public
reporting practices. An unnamed state agency has also reportedly submitted an
information request to the Company. Based on this news, shares of CareDx
crashed by more than 25% on October 29, 2021.
If you are a shareholder who
suffered a loss, click here to
participate.
We also encourage you to contact
Brian Schall of the Schall Law Firm, 2049
Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also
reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The class in this case has not
yet been certified, and until certification occurs, you are not represented by
an attorney. If you choose to take no action, you can remain an absent class
member.
The Schall Law Firm represents
investors around the world and specializes in securities class action lawsuits
and shareholder rights litigation.
This press release may be
considered Attorney Advertising in some jurisdictions under the applicable law
and rules of ethics.
CONTACT:
The Schall
Law Firm
Brian Schall, Esq.
310-301-3335
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.